SCHEMBL239996

SCHEMBL239996

SCCC(CCS)(CCS)c1cc[c]cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL241424 0.86
SCHEMBL241395 0.80
SCHEMBL240140 0.76
SCHEMBL238009 0.76
SCHEMBL240742 0.73
SCHEMBL243213 0.73
SCHEMBL241628 0.73
SCHEMBL241782 0.71 ALDH1A1 (0.30)
SCHEMBL240529 0.70
SCHEMBL28644802 0.70 ESR1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897992-B1 FUNCTIONALIZED RESINS OBTAINED VIA OLEFIN METATHESIS EXXONMOBIL CHEMICAL PATENTS INC (US) 2017-11-08 EP claimed
EP-2785763-A1 FUNCTIONALIZATION OF VINYL TERMINATED POLYMERS BY RING OPENING CROSS METATHESIS ExxonMobil Chemical Patents Inc. (US) 2014-10-08 EP claimed
US-20140088277-A1 Functionalized Resins Obtained Via Olefin Metathesis EXXONMOBIL CHEMICAL PATENTS INC. 2014-03-27 US claimed
US-8524930-B2 Class of olefin metathesis catalysts, methods of preparation, and processes for the use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-09-03 US claimed
WO-2013081726-A1 FUNCTIONALIZATION OF VINYL TERMINATED POLYMERS BY RING OPENING CROSS METATHESIS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-06-06 WO claimed
US-20130137829-A1 Functionalization of Vinyl Terminated Polymers by Ring Opening Cross Metathesis EXXONMOBIL CHEMICAL PATENTS INC. 2013-05-30 US claimed
WO-2012166259-A2 A NOVEL CLASS OF OLEFIN METATHESIS CATALYSTS, METHODS OF PREPARATION, AND PROCESSES FOR THE USE THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-12-06 WO claimed
US-8173630-B2 Multipodal tethers for high-density attachment of redox-active moieties to substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-05-08 US claimed
CN-117881432-A Porphyrin-hydrogen porphyrin compounds, compositions comprising the same, and methods of use thereof 北卡罗莱纳州立大学 2024-04-12 CN disclosed
US-20230220179-A1 Processes for Producing Cyclic Olefins from Polymers and Re-Polymerization Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2023-07-13 US disclosed
EP-4157813-A1 PROCESSES FOR PRODUCING CYCLIC OLEFINS FROM POLYMERS AND RE-POLYMERIZATION THEREOF ExxonMobil Chemical Patents Inc. (US) 2023-04-05 EP disclosed
WO-2021242636-A1 PROCESSES FOR PRODUCING CYCLIC OLEFINS FROM POLYMERS AND RE-POLYMERIZATION THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-12-02 WO disclosed
US-10919904-B2 Northern-southern route to synthesis of bacteriochlorins NORTH CAROLINA STATE UNIVERSITY (US) 2021-02-16 US disclosed
US-10836774-B2 Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds NORTH CAROLINA STATE UNIVERSITY (US) 2020-11-17 US disclosed
US-20070108438-A1 Multypodal tethers for high-density attachment of redox-active moieties to substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-05-17 US disclosed
WO-2007018808-A2 METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF PORPHYRINS NORTH CAROLINA STATE UNIVERSITY (US) 2007-02-15 WO disclosed
WO-2007018807-A2 METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF PORPHYRINS NORTH CAROLINA STATE UNIVERSITY (US) 2007-02-15 WO disclosed
US-20070027311-A1 Methods and intermediates for the synthesis of porphyrins NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-02-01 US disclosed
US-20070027312-A1 Methods and intermediates for the synthesis of porphyrins NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-02-01 US disclosed
US-20060194960-A1 infections, burns, sepsis, ulcers, periodontal disease, atherosclerosis, cosmetic and dermatologic conditions, acne, tissue sealing, neoplastic disease or cancer; active agents in photodynamic therapy, luminescent compounds in flow cytometry, solar cells, light harvesting arrays, molecular memory devices NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-08-31 US disclosed